Collegium Pharmaceutical Inc (COLL) Net earnings per share growth forecast for next year

Corporate emblem and logo of Collegium Pharmaceutical Inc (COLL)

The forward earnings per share growth forecast demonstrates Collegium Pharmaceutical (COLL) battling regulators and generics through unique defensive technologies. Agile management is successfully diversifying the portfolio by integrating new assets. Stable income is secured by patents for chronic pain medications, and -5.30 serves as the final mark for this metric.

Collegium Pharmaceutical Inc (COLL): Net earnings per share growth forecast for next year from 07/04/2022 to 11/14/2026

Metric breakdowns and analytics for collegiumpharma.com (COLL)

- share price and consensus valuation forecast:
Stock Price Collegium Pharmaceutical Inc|COLL - Consensus Target
- market capitalization details:
Market Value Collegium Pharmaceutical|COLL - Total Enterprise Value
- company book value details:
Net Assets per Single Share Collegium Pharmaceutical|COLL - Company Book Value|Market Value to Book Value Ratio collegiumpharma.com|COLL - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Collegium Pharmaceutical|COLL - Long-Term Liabilities to Capital|Short-Term Debt to Capital Collegium Pharmaceutical, Inc.|COLL - Company Total Indebtedness|Debts to Book Capitalization Collegium Pharmaceutical|COLL - Long-Term Debt Volume|Company Current Liabilities Collegium Pharmaceutical|Quick Liquidity collegiumpharma.com
- net income and valuation ratios data:
COLL - Net Income|Future Profit Collegium Pharmaceutical|COLL - Company Value to Net Income|Future Price to Earnings Collegium Pharmaceutical|COLL - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Collegium Pharmaceutical|COLL - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Collegium Pharmaceutical|COLL - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months collegiumpharma.com|COLL - Earnings per share increase in current year|Net earnings per share growth forecast for next year Collegium Pharmaceutical
- company sales and revenue statistics:
COLL - Company Sales|Projected Sales Volume Collegium Pharmaceutical Inc|COLL - P/S Multiple|Forward P/S Multiple Collegium Pharmaceutical
Analysis of all company metrics:Collegium Pharmaceutical Inc, COLL
Finished products of collegiumpharma.com

This metric measures the expected increase in earnings per share, reflecting the analysts' consensus forecast for the business's operational efficiency. The current value of -5.30 is based on the potential for implementing proprietary drug delivery technologies in the US, allowing investors to assess the risk of overpayment by analyzing the projected annual EPS dynamics of Collegium Pharmaceutical (COLL) on this chart.

Competitor analysis

INDV (Indivior Group) - Earnings growth forecast for next year|Expected earnings per share growth for next year Cronos Corp (CRON)|Net earnings per share growth forecast for next year Canopy Growth (CGC)|HITI - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aurora Cannabis Inc. ACB|Achieve Life Sciences Inc. - Net earnings per share growth forecast for next year|SKYE - Net earnings per share growth forecast for next year|ANEB: Net earnings per share growth forecast for next year|INCR: Earnings growth forecast for next year|Expected net earnings per share growth next year Nutriband (NTRB)|NSRX (Nasus Pharma Ltd.) - Earnings growth forecast for next year|IGC - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year MIRA|Consensus forecast of earnings per share growth for next year Flora Growth Inc|IM Cannabis - Expected earnings per share growth for next year|Earnings growth forecast for next year Adial Pharmaceuticals Inc. ADIL|ARTL - Net earnings per share growth forecast for next year|Ensysce Biosciences (ENSC) - Expected earnings per share growth for next year|TTNP (titanpharm.com) - Expected earnings per share growth for next year|Greenlane Corp - Expected earnings per share trend next year|Net earnings per share growth forecast for next year InMed Pharmaceuticals|akandacorp.com - Net earnings per share change forecast for next year|Earnings growth forecast for next year ENVB|BGXX (brightgreen.us) - Expected earnings per share trend next year|Earnings growth forecast for next year HPCO (Hempacco Co., Inc.)